Colgate-Palmolive (NYSE:CL) Downgraded by Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive (NYSE:CL) from a buy rating to a hold rating in a research report released on Monday morning, MarketBeat.com reports. Deutsche Bank Aktiengesellschaft currently has $109.00 target price on the stock, up from their previous target price of $107.00.

A number of other research firms have also weighed in on CL. Morgan Stanley raised their target price on shares of Colgate-Palmolive from $103.00 to $111.00 and gave the company an overweight rating in a report on Monday, July 29th. HSBC reaffirmed a hold rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Bank of America lifted their price objective on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the stock a buy rating in a research note on Wednesday, July 10th. UBS Group lifted their price objective on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a buy rating in a research note on Wednesday, September 4th. Finally, Hsbc Global Res lowered shares of Colgate-Palmolive from a strong-buy rating to a hold rating in a research note on Friday, July 26th. Nine equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of Moderate Buy and a consensus target price of $102.63.

Colgate-Palmolive Trading Down 0.7 %

CL stock opened at $106.09 on Monday. The firm has a fifty day moving average price of $101.72 and a 200 day moving average price of $94.96. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The firm has a market cap of $87.04 billion, a PE ratio of 33.57, a price-to-earnings-growth ratio of 3.78 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm had revenue of $5.06 billion during the quarter, compared to analyst estimates of $5 billion. During the same period last year, the firm posted $0.77 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 4.9% compared to the same quarter last year. Sell-side analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Insider Activity at Colgate-Palmolive

In related news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now directly owns 13,942 shares in the company, valued at $1,439,929.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the transaction, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock worth $4,486,063 over the last three months. 0.34% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Colgate-Palmolive

Large investors have recently added to or reduced their stakes in the company. E Fund Management Hong Kong Co. Ltd. bought a new position in Colgate-Palmolive in the second quarter worth about $25,000. Union Savings Bank raised its holdings in Colgate-Palmolive by 76.6% in the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock worth $25,000 after purchasing an additional 134 shares in the last quarter. PSI Advisors LLC increased its holdings in shares of Colgate-Palmolive by 4,971.4% during the first quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after acquiring an additional 348 shares in the last quarter. Continuum Advisory LLC increased its holdings in shares of Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares in the last quarter. Finally, Atlantic Edge Private Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at about $32,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.